Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Choose from a selection of modern and traditional designs in single or twin packs to support type 1 diabetes research this Christmas. Shop online and get fast delivery.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This legendary half marathon sees 60,000 runners take to the streets of Newcastle, crossing the iconic Tyne Bridge and finishing in sunny South Shields.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > About Breakthrough T1D UK & our impact > Our research > Research projects > Developing a simple tool to help people with type 1 diabetes exercise
Although regular exercise is important for us all, most people with type 1 diabetes (T1D) don’t exercise regularly. This is often because they are worried about their blood glucose going too low, and don’t have the right tools to help keep them under control. Dr Richard Pulsford from the University of Exeter is developing a simple tool that could help people with T1D exercise.
Exercise is good for everyone, but it has even more benefits if you have T1D. It can help keep blood glucose levels more stable in the long term and increase how sensitive you are to insulin, meaning you might not need to take as much. Exercise can also help prevent long-term T1D complications, particularly heart disease, and improve mental health.
Exercise affects everyone with T1D differently, and different forms of exercise can affect blood glucose in different ways. Aerobic exercise like swimming, cycling or running usually causes them to drop. When Richard asked people with T1D why they don’t exercise regularly, the main reasons were that they are worried about their blood glucose going too low, called a ‘hypo’, and don’t have the tools to help keep them under control. Learn more about T1D and exercise.
Richard is developing a visual tool called ‘GlucoseGo’ that predicts someone’s likelihood of having a hypo during exercise based on simple information (their blood glucose before they start exercise and how long they plan to exercise for). GlucoseGo is displayed as a simple traffic-light heatmap, which could support people with T1D to exercise and reduce hypos.
Richard said:
“Exercise is so important, but when we have asked people living with T1D about exercise they have told us that concerns about having a hypoglycaemic episode during exercise sometimes stop them from taking part, and that they don’t feel like there are tools to help. We have been developing simple tools to help people understand the likelihood of them having a hypoglycaemic episode based on simple information about them and the exercise they would like to do. In this project children with T1D will help us design what these tools should look like, where they should be available and how they should be used. We hope this will make them useful for as many people as possible”
In this project, Richard will use information on exercise and blood glucose from children under 12 to test if GlucoseGo works in this age group. Richard will then improve the tool by asking adults and children with T1D to help design what it should look like and how it could be used. These people and their doctors will be asked to use GlucoseGo and provide further feedback. At the end of the project, Richard will have a version of GlucoseGo that can be tested in a real-world study to see how helpful it is.
This project will benefit people with T1D by directly addressing an important unmet need. The new tool Richard is developing could help reduce worry about exercise-related hypos, and the number of hypos experienced when exercising. This could encourage people with T1D to exercise more often, improving their general health and blood glucose control, and reducing the risk of long-term T1D complications.
Last year, we conducted some market research that showed people with T1D are held back from exercise due to stigma and fear of hypos. The research highlighted the need for more support for people with T1D around exercise, which Richard’s project could help address.
The survey also highlighted the need for education for people running sport and exercise activities. We’re already working to improve knowledge and education around T1D and exercise through partnering with organisations to produce guidance for coaches, providing information and support online, running regular events on managing T1D and exercise, and working with partners in the healthcare profession, such as EXTOD.
Dr Rebecca Dewhurst-Trigg is investigating how supportive cells called mesenchymal stromal cells may help protect insulin-making beta cells from being destroyed in type 1 diabetes.
Dr Parth Narendran is comparing how effective different treatments are for people newly diagnosed with type 1 diabetes at protecting their remaining insulin-making beta cells.
Dr Mandeep Kaur Marwah is developing a new type of dressing to help diabetic wounds heal more quickly.
Professor Shareen Forbes is investigating whether giving certain immune cells with islet transplants can help the islets survive in the recipient and reduce the need for immune-suppressing drugs.